InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Dalal Anupam, 董事. Director active across 3 companies, notably Aerpio Pharmaceuticals, Inc.. Cumulatively, 6 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €34m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 14 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Dalal Anupam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
1,275,510 股@ US$3.920.25% mcap100.0% 占其流量Common StockSEC:0001602474-26-000004:0
1,561,000 股@ US$2.404.7% 占其流量Common StockSEC:0001415889-25-007096:0
320,000 股@ US$12.505.5% 占其流量Common StockSEC:0001209191-22-051390:0
1,529,402 股@ US$13.07725.0% 占其流量Common StockSEC:0000899243-21-034635:0
标准退出：2021年11月24日 (T+90)
1,529,402 股@ US$13.07768.8% 占其流量Common StockSEC:0000899243-21-034546:0
标准退出：2021年11月24日 (T+90)
7,400 股@ US$1.52100.0% 占其流量Common StockSEC:0000899243-21-027291:0
6 条申报中的 6 条
About Dalal Anupam
Anupam Dalal is a Board Member at Aerpio Pharmaceuticals, Inc. and Aadi Bioscience, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His expertise is valuable for the development of these organizations.
